Hematology

Samir Parekh, MD, on Investigating Treatment Options for Relapsed Myeloma

The director of translational research in myeloma at the Tisch Cancer Institute discussed investigating sequential T cell redirection therapies.

New, Multicenter Trial of MB-106 Doses First Patient

Interim data from an ongoing study demonstrate continuing efficacy in B-NHL, CLL, and FL.

Around the Helix: Cell and Gene Therapy Company Updates – October 5, 2022

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.